Synthesis and Pharmacological Potential of New 3-Mercapto-4-Amino(Pyrrolyl-1)-5-(Thienyl-2)-1,2,4-Triazole(4H) Derivatives
- Autores: Saidov N.B.1, Georgiyants V.A.2, Lipakova E.Y.3
- 
							Afiliações: 
							- Tadzhik National University
- National Pharmaceutical University
- Kharkov Postgraduate Medical Academy
 
- Edição: Volume 51, Nº 1 (2017)
- Páginas: 26-29
- Seção: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244498
- DOI: https://doi.org/10.1007/s11094-017-1551-1
- ID: 244498
Citar
Resumo
A synthesis of 4-amino-5-(2-thienyl)-1,2,4-triazol(4H)-3-ylthioacetanilides was developed, and these were chemically modified to produce 2-[5-(2′-thienyl-4-(1H-1-pyrrolyl)-4H-1,2,4-triazol-3-ylthio]acetanilidfes. The structures of the synthetic compounds were confirmed by 1H NMR spectroscopy. Predictions of pharmacological activity showed that the compounds synthesized here were likely to act on the CNS. The antitumor activity of the study compounds was assessed.
Palavras-chave
Sobre autores
N. Saidov
Tadzhik National University
							Autor responsável pela correspondência
							Email: narzullos@mail.ru
				                					                																			                												                	Tajiquistão, 							Dushanbe						
V. Georgiyants
National Pharmaceutical University
														Email: narzullos@mail.ru
				                					                																			                												                	Ucrânia, 							Kharkov						
E. Lipakova
Kharkov Postgraduate Medical Academy
														Email: narzullos@mail.ru
				                					                																			                												                	Ucrânia, 							Kharkov						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					